Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at William Blair Growth Stock Conference Transcript

Jun 06, 2022 / 07:00PM GMT
Release Date Price: €107 (+1.90%)
Matthew Richard Larew
William Blair & Company L.L.C., Research Division - Research Analyst

Okay. I think we are at 2:00. Good afternoon, everyone. Welcome. Thanks for joining us for the management presentation with Amedisys. My name is Matt Larew. I cover Amedisys here at William Blair.

Pleased to be joined by President and CEO, Chris Gerard; as well as the CFO, Scott Ginn. Nick Muscato, who is Chief Strategy Officer, is in the back. Before we begin the presentation, I just want to mention 2 things. So the breakout session is in Richardson, which is on the second floor right after this presentation. And then for a complete list of disclosures or any conflicts of interest, please visit wiliamblair.com, Again, very pleased to have Amedisys here for another year with us.

With that, I'm going to turn it over to Chris and Scott.

Christopher T. Gerard
Amedisys, Inc. - CEO, President & Director

Great. Thank you. Thanks, Matt. Good afternoon, everybody. My name is Chris Gerard. I'm the President and Chief Executive Officer here at Amedisys

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot